Home / Medicine / Carsil

Carsil

Recorded active ingredients: Silybi mariani fructuum extract

Based on a snapshot of pillintrip.com listings. Country listings do not confirm current availability or registration. Sources and limitations · How matching works.

Countries

Medicines with the same recorded active ingredients

These listings match the full ingredient set recorded for Carsil. Strength, dosage form and route may differ or be missing. This does not establish interchangeability; confirm a suitable product with a pharmacist.

Pharmacy sales terms

Without a prescription.

Pharmacotherapeutic group

  • Hepatoprotective agent [Hepatoprotectors]

Special precautions for storage

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life of the drug Karsil®2 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

Jelly beans 1 dragee
active substance:  
milk thistle spotted fruit extract dry (equivalent to silymarin) 35 mg
excipients  
the core: lactose monohydrate-55.38 mg, wheat starch — 55.38, povidone (collidone 25) - 1.65 mg, MCC-67 mg, magnesium stearate-2.5 mg, talc-7 mg, dextrose monohydrate-20.6 mg, sorbitol-4.13 mg, sodium bicarbonate-1.36 mg  
shell: cellacephate — 0.84 mg, diethyl phthalate — 0.6 mg, sucrose — 162.19 mg, acacia gum — 1.562 mg, gelatin — 0.86 mg, talc — 26.718 mg, titanium dioxide — 4.82 mg, macrogol (PEG 6000) — 0.13 mg, Brown Opalux dye (sucrose, iron oxide red, iron oxide black, methyl and propyl parahydroxybenzoate, water cleaned up) - 2.25 mg, glycerol-0.03 mg  
Release form

Tablets, 35 mg. In blisters made of PVC film and aluminum foil of 10 pcs., in a pack of cardboard 8 or 18 bl.

Nosological classification (ICD-10)

  • B94. 2 Long-term effects of viral hepatitis
  • K70 Alcoholic liver disease
  • K70. 0 Alcoholic fatty liver dystrophy [fatty liver]
  • K71 Toxic liver damage
  • K73. 9 Chronic hepatitis, unspecified
  • K74 Fibrosis and cirrhosis of the liver
  • K76. 0 Fatty liver degeneration, not classified elsewhere
  • K76. 9 Liver disease, unspecified
  • T50. 9 Other and unspecified medicinal products, medicines and biological substances
  • T51 Toxic effects of alcohol
  • T65. 9 Toxic effect of an unspecified substance
  • Y57 Adverse reactions in the therapeutic use of other and unspecified drugs and medications
  • Z57 Occupational exposure to risk factors

Dosage (Posology) and method of administration

Inside.

Take before meals, with a sufficient amount of water.

The duration of the course of treatment is at least 3 months.

Adults and children over 12 years of age: treatment of severe liver damage begins with a daily dose of 420 mg (4 tablets 3 times a day). In milder cases and as maintenance therapy-1-2 tablets 3 times a day.

Prophylactically take 2-3 pills a day.

ATC - Anatomical and therapeutic chemical classification

A05BA03 Silymarin

Listed in 1 countries